Mexican Senator to Initiate Decriminalization and Regulation of Hallucinogenic Substances
Mexican Senate To Decriminalize and Regulate Entheogenic Medicine
The Mexican Senate promised to present a bill on January 26th, 2023 to decriminalize and regulate so-called hallucinogenic substances, such as psilocybin, to treat mental health problems such as depression and anxiety. Senator Alejandra Lagunes, in a statement from her party distributed this Wednesday, assured that “it has been scientifically proven that psilocybin from psilocybin mushrooms, mescaline from peyote and DMT from ayahuasca and the bufo alvarius ’toad’ are not drugs, have high therapeutic potential, low toxicity and do not generate physical dependence no abuse”.
Lagunes also acknowledged the lack of progress made by the Mexican scientific and medical community in researching these substances, and that “since the 1960s, there has been a prohibitionist policy on this type of substance [in the Mexican General Health Law]…considered a psychotropic substance, with zero therapeutic value and as a problem for public health”.
The Senator proposed that Mexico learn from other countries who have made steps towards decriminalization or regulation, and must learn from the regulation of cannabis “so as not to make other mistakes”. Additionally, Lagunes urged to address urgent issues such as “who sells, harvests, produces, gives therapies, how they are certified or not doctors, therapists and if it is only for the native peoples”.
In this initiative, Lagunes wants to integrate both ancestral knowledge and the reality of biomedicine, as well as answer public policy questions, guarantee access, and avoid extractivism. Her goal is for Mexico to not be left behind when it comes to exploring new ways of treating people and mental health.